Company profilePharmaceutical#302 of 1,318 in Pakistan✓ No DRAP alerts

SWISS PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 58 brands · 88 molecules

Ranked #128 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

58 registered products 25 pharmaceutical brands 88 distinct molecules 0 DRAP alerts

Company overview

58
registered products
25
pharmaceutical brands
88
distinct molecules
12
therapeutic classes
0
DRAP alerts

SWISS PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 58 product registrations across 88 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Antibiotics For Topical Use. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Paracetamol4 brands
Diclofenac2 brands
Thiamine2 brands
Nicotinamide2 brands
Pyridoxine2 brands
Neomycin2 brands
Naproxen2 brands
Fusidic Acid2 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 3Antibiotics For Topical Use · 3Antiemetics & Antinauseants · 2Blood Glucose Lowering Drugs, Excluding Insulin · 2Other Beta-Lactam, Cephalosporins & Penems · 2Calcium Channel Blockers · 1Quinolone Antibacterials · 1Corticosteroid Combinations, Topical · 1Lipid Modifying Agents · 1Vitamin B12 Plain · 1Antihaemorrhagic · 1Antihistamines For Systemic Use · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official1 products · Rs 816.58 – Rs 816.58
Median across source: Rs 816.58

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for SWISS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.